LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 572 pages found matching <script>alert('What_Security?')</script>- What Lies Beyond Asbestos Drilling Mud?
Jun-26-13 Washington, DC While there are always risks associated with various industrial activities such as manufacturing, mining and drilling, less-obvious hazards often prove to pose the most risk. With drilling, for oil and gas, the use of drilling mud has evolved to an alleged silent killer due to use of asbestos in the mud itself. Drilling mud is used to cool d... - Amusement Park Ride Accidents Require Quick Action and Evidence
Jun-14-13 Riverview, FL A day at an amusement park can go bad very quickly. A 2013 report by the Nationwide Children’s Hospital in Columbus, Ohio, found that 20 children a day were treated at an emergency ward somewhere in the U.S. for injuries related to an amusement park-type ride. The number of injuries in the study doesn’t surprise Florida att... - Stryker Rejuvenate Hip Implant Failure
The Stryker Rejuvenate hip replacement device has been linked to an increased risk of metallosis. Although the Stryker Rejuvenate is not a metal-on-metal hip device, it has metal-on-metal components, which are believed to be responsible for the development of metallosis in some patients. According to reports, the Stryker Rejuvenate hip implant is linked to... - Valproate Not To Be Used for Migraine During Pregnancy, FDA Warns
Washington, DC: The Food and Drug Administration (FDA) is advising health care professionals and women that the anti-seizure medication valproate sodium (Depakote) and related products, valproic acid and divalproex sodium, are contraindicated and should not be taken by pregnant women for the prevention of migraine headaches. Based on information f... - Signs of Trouble for Incivek from the Day of Approval
Mar-7-13 Washington, DC It was in May, 2011 that Vertex Pharmaceuticals won approval from the US Food and Drug Administration (FDA) for Incivek, a promising new drug to fight hepatitis C to be used in combination with two other drugs. According to The New York Times (5/23/11), Incivek was expected to finally allow Vertex to be profitable after 22 years of operati... - Pfizer to Settle 80 Percent of Chantix Lawsuits
Mar-5-13 Washington, DC More than 80 percent of the 2,700 federal and state Chantix lawsuits facing Pfizer look as if they could be settled. Pfizer, the maker of the controversial smoking cessation drug known generically as varenicline, faces a raft of lawsuits alleging Chantix causes suicide, suicide attempts and other psychiatric disturbances. In order t... - Pfizer Settles 80 Percent of Chantix Lawsuits
Washington, DC: Pfizer, the maker of the controversial smoking cessation drug Chantix (known generically as varenicline), has settled or agreed to settle some 80 percent of the Chantix lawsuits filed over allegations that the drug causes suicide, suicide attempts and other psychiatric disturbances. The settlements equate to roughly four fifths o... - Does Your Doctor Know That Topamax Is Linked to Birth Defects?
Feb-26-13 Washington, DC Chances are, you trust your doctor to provide the best possible treatment for whatever ails you. And you likely don’t question your doctor when he or she prescribes medications for that ailment. However, doctors have the difficult and time-consuming task of familiarizing themselves with drug contraindications. This writer, for one, ask... - Wisconsin Plaintiffs Allege Newborn Daughter Succumbed to SSRI Birth Defects
Feb-6-13 Winnebago County, WI An SSRI birth defects lawsuit filed at the start of the year in US District Court for the Eastern District of Pennsylvania alleges that the Selective Serotonin Reuptake Inhibitor (SSRI) antidepressant the mother continued to take while pregnant resulted in the death of a child. In this case, the SSRI lawsuit centers on the Zolof... - New Diabetes Drug May Compete with Januvia
Feb-2-13 Washington, DC The US Food and Drug Administration (FDA) has approved a new diabetes drug that is expected to compete with Januvia for a share of the diabetes medication market. Although the drug is believed to have heart risks, it is not yet known if the drug’s risks are similar to Januvia side effects. Some studies have suggested a link between... - Insurers Facing More Asbestosis Lawsuits
Dec-21-12 Washington, DC Just last year there were reports that asbestosis lung disease and asbestos lawsuits were decreasing, having peaked about a decade ago. Not so, according to The Wall Street Journal (12/17/12). The insurance industry says previous estimates fell short to the tune of 10 billion dollars. Asbestos was widely used right into the 1970s, a... - Plaintiffs Move to Consolidate GranuFlo Lawsuits
Dec-20-12 Philadelphia, PA In the wake of concerns about the GranuFlo recall and NaturaLyte recall, GranuFlo lawsuits have been filed alleging patients were harmed by the use of Fresnius Medical Care's products. The lawsuits allege both GranuFlo and NaturaLyte did not carry adequate warnings to alert patients to the potential risks associated with the products... - Raptiva Pulled from Market Due to Concerns About Side Effects
Dec-17-12 San Antonio, TX It has been more than three years since Raptiva was voluntarily withdrawn from the market due to concerns about serious Raptiva side effects. Specifically, the drug was pulled after reports surfaced of a reported increased risk of Raptiva PML (progressive multifocal leukoencephalopathy), a rare progressive neurologic disease that is oft... - The Difficulty with Care Center Abuse Cases
Dec-13-12 Palm Beach, FL Although families send their loved ones to care homes for their safety and security, care center abuse cases show that not all homes are created—or run—equally. Issues such as elder abuse, care center physical abuse and neglect are all the focus of myriad care center lawsuits. Although there can be some difficulty in having c... - GranuFlo Recall Still Rankles
Nov-23-12 Lehigh, PA The closure of a billing office by Fresenius Medical Care does not appear to be in any way related to a GranuFlo lawsuit or alkali dosing errors related to the recalled GranuFlo, a product used in association with kidney dialysis. And aside from a recent GranuFlo lawsuit launched against the manufacturer of the now-recalled product, there... - Washington State Nurses Overtime Decision: Employers Alert
Nov-23-12 Spokane, WA In October 2012 the Supreme Court of Washington held that about 1,200 registered nurses in Spokane who worked through their rest periods were entitled to overtime pay under the Washington State Employment law . This decision will likely put many employers on the alert regarding overtime and Washington employee rights. The Nurses overt... - Pradaxa: a Flawed Drug Due to Bleeding
Nov-7-12 Houston, TX When the US Food and Drug Administration (FDA) released the result of a Mini-Sentinel assessment of Pradaxa, the new-age anti-clotting agent that serves as an alternative to the 60-year-old standby warfarin, the regulator noted that Pradaxa bleeding rates do not appear to be any higher than those of warfarin. The assessment, on the surfa... - Januvia Patients Face Increased Risk of Pancreatitis
Nov-3-12 Boston, MA Patients who take type 2 diabetes drug Januvia could face an increased risk of pancreatitis. That was the word from the US Food and Drug Administration (FDA) back in 2009, after the agency received word of serious Januvia side effects, including a link between Januvia and pancreatitis. Januvia was approved to treat adults with type 2 diab... - Montana Couple Launches SSRI Birth Defects Lawsuit
Nov-1-12 Butte, MT The potential for SSRI Birth Defects would have been furthest from the minds of Lisa Rooney and Wayne Halvorsen when their infant daughter arrived in 2009. However, after their baby was born with a severe heart defect allegedly due to the SSRI antidepressant prescribed to Rooney, the Butte couple decided to take legal action. Selective ser... - Study Questions Effectiveness of Statins
Oct-10-12 Raleigh, NC A new study suggests that statins—a class of drug that includes Crestor—may not be as effective as previously thought. That calls into question whether the risk of Crestor side effects , which reportedly include a risk of Crestor issues such as rhabdomyolysis and other health problems, outweigh the potential benefits. The study...